Sign In To Continue
You have reached the guest article limit.
Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.
In a significant precedential ruling, the USPTO Director articulated the discretionary framework guiding institution decisions for America Invents Act (AIA) reviews, including inter partes reviews (IPRs). The decision in Magnolia Medical Technologies, Inc. v. Kurin, Inc. emphasizes considerations such as public intere…
Share This Article
Ready-to-post copy includes the article link.
USPTO Director Clarifies Discretionary Standards in Denying Inter Partes Review in Magnolia Medical Case In a significant precedential ruling, the USPTO Director articulated the discretionary framework guiding institution decisions for America Invents Act (AIA) reviews, including inter partes reviews (IPRs). The decision i... Read the full IIPLA article: https://iipla.org/news/uspto-director-clarifies-discretionary-standards-in-denying-inter-partes-review-in-magnolia-medical-case